Toyota H - Search Results

1

Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax.

Toyota H, Yanase N, Yoshimoto T, Moriyama M, Sudo T, Mizuguchi J. Toyota H, et al. Cancer Lett. 2003 Jan 28;189(2):221-30. doi: 10.1016/s0304-3835(02)00552-9. Cancer Lett. 2003. PMID: 12490315

2

Requirement of c-Jun N terminal kinase and P38 mitogen-activated protein kinase for anti-IgM-induced reduction in mitochondrial membrane potential in CH31 B lymphoma cells.

Takada E, Toyota H, Furuhata M, Suzuki J, Mizuguchi J. Takada E, et al. Among authors: toyota h. Immunol Lett. 2002 Apr 22;81(2):93-8. doi: 10.1016/s0165-2478(02)00002-0. Immunol Lett. 2002. PMID: 11852113

3

Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins.

Shibuya H, Kato Y, Saito M, Isobe T, Tsuboi R, Koga M, Toyota H, Mizuguchi J. Shibuya H, et al. Among authors: toyota h. Melanoma Res. 2003 Oct;13(5):457-64. doi: 10.1097/00008390-200310000-00004. Melanoma Res. 2003. PMID: 14512787

4

Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Toyota H, Kondo S, Kyo S, Mizuguchi J. Toyota H, et al. Anticancer Res. 2006 Jan-Feb;26(1A):99-105. Anticancer Res. 2006. PMID: 16475685 Free article.

5

Thy28 partially prevents apoptosis induction following engagement of membrane immunoglobulin in WEHI-231 B lymphoma cells.

Toyota H, Jiang XZ, Asakura H, Mizuguchi J. Toyota H, et al. Cell Mol Biol Lett. 2012 Mar;17(1):36-48. doi: 10.2478/s11658-011-0034-8. Epub 2011 Dec 2. Cell Mol Biol Lett. 2012. PMID: 22139584 Free PMC article.

6

Bcl-x(L) confers multi-drug resistance in several squamous cell carcinoma cell lines.

Noutomi T, Chiba H, Itoh M, Toyota H, Mizuguchi J. Noutomi T, et al. Among authors: toyota h. Oral Oncol. 2002 Jan;38(1):41-8. doi: 10.1016/s1368-8375(00)00098-1. Oral Oncol. 2002. PMID: 11755820

7

Etoposide-mediated sensitization of squamous cell carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced loss in mitochondrial membrane potential.

Itoh M, Noutomi T, Toyota H, Mizuguchi J. Itoh M, et al. Among authors: toyota h. Oral Oncol. 2003 Apr;39(3):269-76. doi: 10.1016/s1368-8375(02)00114-8. Oral Oncol. 2003. PMID: 12618199

8

Modulation of mThy28 nuclear protein expression during thymocyte development.

Jiang X, Toyota H, Takada E, Yoshimoto T, Kitamura T, Yamada J, Mizuguchi J. Jiang X, et al. Among authors: toyota h. Tissue Cell. 2003 Dec;35(6):471-8. doi: 10.1016/s0040-8166(03)00073-9. Tissue Cell. 2003. PMID: 14580360

9

Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.

Kato S, Shirato K, Imaizumi K, Toyota H, Mizuguchi J, Odawara M, Che XF, Akiyama S, Abe A, Tomoda A. Kato S, et al. Among authors: toyota h. Oncol Rep. 2006 Apr;15(4):843-8. Oncol Rep. 2006. PMID: 16525669

10

C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines.

Mikami T, Koyama T, Koyama T, Imakiire A, Yamamoto K, Furuhata M, Toyota H, Mizuguchi J. Mikami T, et al. Among authors: toyota h. Anticancer Res. 2006 Mar-Apr;26(2A):1153-60. Anticancer Res. 2006. PMID: 16619517 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters